Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone efficacy and side effects study in schizophrenia
ChiCTR-TCC-09000584Phase 4Completed
- Sponsor
- The Second Xiangya Hospital
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of risperidone in schizophrenia (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Norepinephrine, gamma-aminobutyric acid and 3 more. Started Sep 2009; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-TCC-09000584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TCC-09000584.